Original Research
Published on 03 Jun 2022
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.867822
- 4,378 views
- 10 citations
